APA (7th ed.) Citation

W, C., A, T., PB, B., H, K., SF, T., & H, Y. (2017). Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy. Molecular pharmacology, 91(4), 317. https://doi.org/10.1124/mol.116.106781

Chicago Style (17th ed.) Citation

W, Chen, Tankovic A, Burger PB, Kusumoto H, Traynelis SF, and Yuan H. "Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy." Molecular Pharmacology 91, no. 4 (2017): 317. https://doi.org/10.1124/mol.116.106781.

MLA (9th ed.) Citation

W, Chen, et al. "Functional Evaluation of a De Novo GRIN2A Mutation Identified in a Patient with Profound Global Developmental Delay and Refractory Epilepsy." Molecular Pharmacology, vol. 91, no. 4, 2017, p. 317, https://doi.org/10.1124/mol.116.106781.